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ABSTRACT
Pancreatic malignancies can be subdivided into endo-
crine and non-endocrine processes. Of the non-endo-
crine tumours, ductal carcinoma is the most common,
and the ductal carcinomas can be further subdivided
into adenocarcinomas and squamous cell carcinomas.
The adenocarcinomas constitute most of the non-en-
docrine pancreatic malignancies, and the treatment
options for these, although limited in efficacy, are rela-
tively well established. The squamous cell carcinoma
pathology is a rare entity, and few reports of it are found
in the literature. As a result, treatment options for sq-
uamous cell carcinoma of the pancreas are poorly un-
derstood. Here, we report the presentation of a
48-year-old woman with metastatic squamous cell
carcinoma of the pancreas. The subsequent investiga-
tions, treatment, and outcome are described.
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1. INTRODUCTION
Pancreatic squamous cell carcinoma is an extremely
rare subtype of pancreatic cancer of ductal origin. It is
poorly understood with respect to causation, risk fac-
tors, biologic behaviour, and response to chemothera-
peutic agents. Here, we present the case of a 48-year-old
woman with a diagnosis of pancreatic squamous cell
carcinoma, with a review of the existing literature, in-
cluding case reports and review articles.
2. CASE PRESENTATION
A 48-year-old woman presented to her local emergency
department on July 9, 2006, complaining of fatigue,
anorexia and weight loss, nausea and vomiting, and
upper abdominal and back pain. These symptoms had
all developed in rapid succession over the course of 3
weeks. She had also noted jaundice. Investigations done
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and elevated bilirubin of 100 μmol/L. The woman was
treated for the pain and nausea, and an outpatient ab-
dominal ultrasound was booked for July 24, 2006.
Ultrasound showed dilatation of both the common
bile duct (17 mm) and the pancreatic duct (5 mm).
The head of pancreas could not be evaluated. A slight
contour deformity measuring 3.5 × 3.5 × 2.0 cm was
also seen in the left hepatic lobe. Computed tomogra-
phy (CT) imaging was recommended. On August 3,
2006, the patient underwent triphasic abdominal CT for
further evaluation of her hepatopancreaticobiliary
anatomy. Enlargement of the pancreatic head and unci-
nate process (measuring 4.4 × 4.2 cm) was observed at
this time. No calcification or hyper-enhancement was
identified. The enlarged pancreatic head was obstruct-
ing both the pancreatic and the common bile duct and
was abutting the superior mesenteric vein on the right
to almost 180 degrees. The CT results also showed dila-
tation of both the biliary and the pancreatic duct, two
hepatic lesions (both in segment 3), and a 14-mm
hypodense nodule in the spleen.
A provisional diagnosis of pancreatic carcinoma
with liver metastasis was postulated. The patient under-
went endoscopic retrograde cholangiopancreatography
on August 14, 2006, for palliative decompression of the
biliary and pancreatic ducts. This procedure failed sec-
ondary to significant narrowing of the second portion
of duodenum.
The patient was admitted (same day) to hospital
for consideration of palliative gastrojejunostomy and
choledochojejunostomy. Examination on admission
showed a jaundiced lady with normal vital signs. Res-
piratory and cardiac examination was unremarkable.
Abdominal examination showed a palpable mass in
the right upper quadrant along the liver edge. Labora-
tory investigations revealed a bilirubin of 321 μmol/L,
alanine transaminase of 247 U/L, alkaline phosphatase
of 900 U/L, and a prothrombin time (international nor-
malized ratio) of 1.6. The patient went to the operating
room on August 16, 2006. She underwent gastrojeju-
nostomy, choledochojejunostomy, open cholecystec-
tomy, and hepatic lesion biopsy. The primary tumour
was left in place. Pathology from the hepatic biopsy
showed metastatic poorly differentiated squamous cellCARCINOMA OF THE PANCREAS
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carcinoma (Figure 1). Desmoplastic stroma surround-
ing neoplastic clusters was noted. The patient was dis-
charged from hospital within 1 week and was referred
to both medical oncology and palliative care.
On September 19, 2006, the patient was seen in a
medical oncology clinic, where she underwent further
evaluation to rule out other primary sources of squa-
mous cell carcinoma. A 35 pack–year history of smok-
ing was noted. Physical examination also revealed a
small left mandibular mass (2 × 2 cm) of 6 months’
duration, and a slight facial deviation. Given the his-
tory and physical exam, concern arose with respect to
a lung or head-and-neck primary. However, imaging
of head, neck, and chest by CT on October 4 revealed
no intracranial pathology, and no suspicious pulmonary
nodules were noted. The patient underwent core bi-
opsy of the mandibular lesion, which showed a benign
intravascular pyogenic granuloma.
The final diagnosis was squamous cell carcinoma
of the pancreas with metastatic disease to liver. The
decision of the gastrointestinal tumour group was to
treat with palliative chemotherapy using a lung chemo-
therapy protocol of gemcitabine and carboplatin. The
patient underwent 2 cycles of chemotherapy, but died
November 15, 2006.
3. DISCUSSION
The pancreas can be involved by a variety of neoplastic
processes, both endocrine and non-endocrine. Endo-
crine tumours can originate from the islets of Langer-
hans. Non-endocrine tumours can be classified into the
following histologic subdivisions 1–3:
￿ Duct cell origin
￿ Acinar cell origin
￿ Mixed cell type
￿ Connective tissue origin
￿ Uncertain histogenesis
Ductal carcinoma is the most common pancreatic
cancer, and this classification is further subdivided into
adenocarcinoma and (the rare) squamous cell carci-
noma. The classic adenocarcinoma constitutes about
75%–81% of all pancreatic cancers, and so it is by far
the most common pancreatic malignancy 1,2,4,5.
Pure squamous cell carcinoma of the pancreas is
so rare that is not mentioned in most textbooks dealing
with pancreatic malignancies 1. It has various reported
incidence rates, ranging from 0.5% to as high as 5% of
pancreatic ductal carcinoma 2,4,5–13. Halpert and his
group (as quoted by Brown et al.) in their series of 120
patients, described an incidence rate of 5% pure squa-
mous pathology 5. However, in a much larger series
review such as Baylor and Berg (5075 patients), the
reported incidence of pure squamous cell carcinoma
was 0.5% of the pancreatic ductal carcinomas 14. Of
the 1300 cases of pancreatic cancers observed at au-
topsy in a survey in Japan in 1992, 0.7% were squa-
mous cell carcinoma 7. However, no cases of squamous
cell carcinoma were found in the 1211 pancreatic car-
cinomas compiled from registries for pancreatic can-
cer in Japan (as quoted by Anagnostopoulos et al.) 8.
This discrepancy in the reported incidence rates can
be explained in part by the fact that some of the cases
represent adenosquamous carcinoma rather than pure
squamous cell carcinoma of pancreas 8. Because of
its rarity, squamous cell carcinoma of the pancreas is
typically diagnosed only after other primary sources
have been excluded by appropriate diagnostic tests, and
only after the presence of a glandular component has
been ruled out using multiple-cut specimens and sev-
eral histologic techniques 15.
Normally, the pancreas is totally devoid of squa-
mous cells. It is not uncommon to find squamous
metaplasia of the ductal columnar cells during periods
of inflammation, such as in pancreatitis, and in fact,
squamous cell carcinoma of the pancreas has been
thought to arise from ductules that have undergone
squamous metaplasia secondary to chronic inflamma-
tion 3. Atypical squamous epithelium can also be seen
in cytologic specimens obtained from pancreatic le-
sions arising from other than inflammatory conditions—
for example, chronic pancreatitis. These conditions may
include squamous metaplasia related to pancreatic or
biliary duct stent placement, and primary or metastatic
squamous cell carcinoma 10. Differentiation between
the atypical squamous epithelium of benign conditions
and the cytologic aspirates of carcinoma is possible by
noting the small number of atypical cells and the lower
degree of nuclear atypia found in the former condition
10. Squamous metaplasia of the pancreatic ducts is
found in 9%–64% of pancreases routinely examined at
necropsy, and despite the relative frequency of squa-
mous metaplasia, transformation to squamous cell car-
cinoma of pancreas is an extremely rare occurrence 4–6,8.
FIGURE 1   Hepatic biopsy showing normal liver in lower quadrant,
with neoplastic clusters (arrows) of metastatic squamous cell
carcinoma (hematoxylin and eosin stain, 20x× magnification).AL-SHEHRI et al.
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Multiple theories have been postulated to explain
the development of pancreatic squamous cell carci-
noma. These include 4,7–9,13
￿ malignant change in a primitive cell capable of
differentiating into either squamous or glandular
carcinoma,
￿ squamous change in a pre-existing adenocarcinoma,
￿ malignant transformation in a squamous metapla-
sia of the ductal epithelium,
￿ malignant change in an aberrant squamous cell,
and
￿ the theory of tumour collision.
Clinicopathologic and immunohistochemical stud-
ies have helped little in clearing the confusion raised by
these theories. Given the absence of any glandular com-
ponent in the pancreatic specimens of our patient, the
first two of the above-mentioned theories are unlikely
origins for her pancreatic squamous cell carcinoma.
In a consideration of the various theories of the
development of primary pancreatic squamous cell car-
cinoma, metastatic squamous cell carcinoma of the
pancreas should be noted to be a far more common
cause of malignant pancreatic squamous cell carci-
noma lesions than the development of a primary squa-
mous cell carcinoma. Cubilla and Fitzgerald (as quoted
by Layfield et al.) in their autopsy study, did not find a
primary squamous cell carcinoma of pancreas, but 261
of 411 neoplasms within the pancreas were metastatic,
with 49 metastases being from the lung, 12 from the
cervix, and 10 from the esophagus 10. Statistically, the
presence of pure squamous cell carcinoma in the pan-
creas favours a metastatic lesion until proven other-
wise, and appropriate radiographic and endoscopic
evaluations are needed to rule out this possibility.
No specific known risk factors exist for the devel-
opment of primary squamous cell carcinoma of the
pancreas other than the classical risk factors associ-
ated with the more common ductal adenocarcinoma.
In one of the theories noted earlier, pancreatic squa-
mous cell carcinoma has been postulated to arise from
ductules that have undergone squamous metaplasia
secondary to chronic inflammation 3, and most, if not
all, instances of pancreatic squamous cell carcinoma
are associated with chronic pancreatitis 1. Mikal and
Campbell, as quoted by Sears et al., reported pancrea-
titis in 49 of 100 autopsied cases with pancreatic car-
cinoma, and Gambill, as quoted by Sears et al.,
showed significant pancreatitis by histologic criterion
in 26 of 225 patients with pancreatic and ampullary
carcinoma 1. These pathology studies suggest that
chronic pancreatitis may be associated with pancre-
atic carcinoma, but they could not specifically evalu-
ate whether the malignant changes developed from the
inflammatory lesions 1.
Calcifications occur in 1%–4% of all pancreatic
cancers. Calcifications probably represent foci of
hemorrhages that occurred in the core of the mass or
episodes of peri-neoplastic pancreatitis 12. A number
of investigators have found that the combination of
pancreatic calcification and chronic pancreatitis is as-
sociated with pancreatic cancer. Currently, no evidence
supports a cause–effect relationship between pancrea-
titis and carcinoma 1.
Questions have been raised about the relationship
between cholelithiasis and pancreatic cancers, and
there may be a higher incidence of cholelithiasis in
women with pancreatic cancer, but no good existing
controlled studies prove this hypothesis 1. Bell, in his
review of 609 autopsied pancreatic cancer patients,
concluded that carcinoma of the pancreas is unrelated
to cholelithiasis 16.
The biologic behaviour of pancreatic squamous cell
carcinoma appears to be similar to that of the much
more common ductal adenocarcinoma. Both tend to
occur in older people, are usually metastatic at the time
of diagnosis, respond poorly to chemotherapy and ra-
diotherapy, and are generally associated with very short
survival 2,3,13. In an analysis of 25 patients, mean age
at diagnosis of pancreatic squamous cell carcinoma
was 62 years (range: 33–80 years) 5. Another analysis
of 6 patients reported a mean age of 65 years 4. Other
studies revealed that 92% of pancreatic squamous
cell carcinomas occur in patients over the age of 50
years 2,9,13. The analysis of the 25 cases did not show
a significant sex preference (there were 14 men and
11 women in the group) 5, and so pancreatic squamous
cell carcinoma seems to affect both sexes equally.
The clinical presentation of pancreatic squamous
cell carcinoma is indistinguishable from that of adeno-
carcinoma, with the most common presenting symp-
toms being abdominal and back pain, anorexia and
weight loss, nausea and vomiting, and obstructive jaun-
dice. Obtaining the exact diagnosis before surgery or
autopsy is therefore difficult 2–6,8,9,13. One of the unu-
sual presentations is upper gastrointestinal bleeding and
melena secondary to gastric invasion 17.
The anatomic head, tail, and body of the pancreas
seem to be affected equally by squamous cell carci-
noma 4–6. In one report, tumour was located in the head
of the pancreas in 73% of cases, the body in 45%, and
the tail in 23% (there is some overlap because the tu-
mour may span more than one portion of the organ) 2.
Mean tumour size as reported by Brown et al. in the
review of 25 cases with detailed data was 7.8 cm 5.
Approximately 95% of patients show evidence of dis-
seminated or locally metastatic disease at the time of
initial evaluation or laparotomy 2, with the regional
lymph nodes, liver, lung, and bones being most com-
monly targeted 4,13.
No specific laboratory investigation is helpful in
the diagnosis or monitoring of pancreatic squamous cell
carcinoma. However, two reports discussed the role
of squamous cell carcinoma antigen (Ag) in diagnos-
ing and monitoring the disease. Hachiya, as quoted by
Minami et al., reported that the serum squamous cell
carcinoma Ag level was very high in a patient withCARCINOMA OF THE PANCREAS
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pancreatic squamous cell carcinoma 17. Minami et al.
also reported an elevated level of squamous cell carci-
noma Ag (14.9 U/mL) upon diagnosis, which immedi-
ately delined to within normal limits after complete
resection of the tumour 17. This finding suggests that
the level of serum squamous cell carcinoma Ag may
be a useful marker for tumour recurrence, but the as-
sociation requires further validation.
Hypercalcemia is another laboratory finding that
has been reported in pancreatic squamous cell carci-
noma without evidence of bony metastasis. This
hypercalcemia is thought to be mediated through vari-
ous humoral mechanisms, including parathyroid hor-
mone, parathyroid hormone–like peptides,
prostaglandins, vitamin D–like sterols, and osteoclast
activating factor 3.
Two radiographic features—enhancement of the
tumour on contrast CT, and tumour blush patterns on
angiography—have been reported to aid in the differ-
entiation of pancreatic squamous cell carcinoma and
classical ductal adenocarcinoma. Both of these radio-
graphic phenomena are probably a result of the
hypervascularity of squamous cell carcinoma 3,7,17–19.
Fajardo et al. 18 reported the use of dynamic CT with a
bolus injection of intravenous contrast to examine a
patient with pancreatic squamous cell carcinoma. The
attenuation of this tumour increased from 35 HU to 61
HU. Sprayregen et al. also reported the angiographic
features of two cases of squamous cell carcinoma of
the pancreas 20. Tumour blushes were present in both
cases, and one case showed hypervascularity. He con-
cluded that these features may help to differentiate
squamous cell carcinoma from the typical pancreatic
adenocarcinoma 20.
Although the foregoing radiologic features are unu-
sual in typical ductal adenocarcinoma of the pancreas
and are more suggestive of pancreatic squamous cell
carcinoma, hypervascular radiographic features can be
seen in other conditions such as cystadenoma and cys-
tadenocarcinoma, adenosquamous carcinoma,
hemangioma, angiosarcoma, leiomyosarcoma, and is-
let cell tumours of the pancreas 3,18. However, squa-
mous cell carcinoma should be included in the
differential diagnosis when hypervascularity or a tu-
mour blush is demonstrated in the pancreas 20.
Histology findings characteristic of squamous cell
carcinoma of the pancreas frequently reported in the
literature include keratinization with eosinophilic cy-
toplasm on hematoxylin and eosin staining, the forma-
tion of whorls or “pearls” with intercellular bridges,
and irregularly shaped nests and cords of epithelial cells.
Desmoplastic response secondary to ductal obstruc-
tion may be a prominent feature 3,4. No criteria exist
for the cytologic distinction of metastatic from primary
pancreatic squamous cell carcinoma 10, and this situa-
tion again emphasizes the importance of searching for
another primary source.
Several options for treating pancreatic squamous
cell carcinoma are described in the literature. They
include surgical resection, chemotherapy, and radio-
therapy, with curative resection being the best thera-
peutic option in the appropriate setting. Unfortunately,
most cases (more than 80%) are metastatic or locally
advanced at the time of diagnosis, which makes cura-
tive tumour resection impossible 12,17. A number of
chemotherapeutic options have been tried, including
the combination of cisplatin and 5-fluorouracil or vin-
blastine 4,5. One report described better response to
chemoradiotherapy regimens based on gemcitabine 8.
Ravry, as quoted by Itani et al., reported an objective
response with striking symptomatic improvement with
bleomycin in 1 of 2 patients with the squamous cell
variety of pancreatic cancer 4; however, no standard
chemotherapy regimen has been established. Our
gastrointestinal tumour group elected to treat our pa-
tient with a combination of gemcitabine and carboplatin
on a palliative basis, given the modest efficacy of these
drugs in treating squamous cell carcinoma of the lung.
The literature on squamous cell carcinoma has
reported a variety of median survivals, with one study
showing a median survival of 7 months (range: 6–16
months) for patients who underwent curative resection
and 3 months (range: 0.25–9 months) for patients who
did not undergo curative resection 5. Within the various
studies, the median survival was generally poor, with
1-year and 5-year survival rates of 4.8% and 1% re-
spectively 3,11–13,19. Two reports showed a similar
mean survival for the two histologically different pan-
creatic tumour types, but it would appear that prognosis
for the squamous cell type may be worse than that of
the usual adenocarcinoma of the pancreas 1–3,11–13,19.
4. CONCLUSIONS
Primary pancreatic squamous cell carcinoma is such
a rare event that the finding of pure squamous cell car-
cinoma on pancreatic carcinoma biopsy warrants an
extensive workup to rule out the possibility of other
more common primary sources, including head-and-
neck, lung, and esophagus. The disease is highly ag-
gressive, most often locally advanced or metastatic at
diagnosis, and poorly responsive to chemotherapy or
radiotherapy; it also has generally poor survival rates.
Based on the rare incidence of this histologic subtype
of pancreatic carcinoma, advancing diagnosis and treat-
ment will remain an enormous challenge.
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